Evaluación de la enfermedad de Alzheimer en etapa temprana: biomarcadores y pruebas neuropsicológicas
Date
2012
Type:
Artículo
item.page.extent
item.page.accessRights
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
Alzheimer disease is a neurodegenerative condition that affects cognitive, behavioral and global functioning of patients. Currently and due to the lack of conclusive biological testing, Alzheimer's disease diagnosis is based primarily on clinical criteria. Since its early diagnosis allows clinical interventions when neurological damage is relatively mild, the development of early detection tools has become a major topic of interest. In this article, we review the main neurobiological and neuropsychological features of Alzheimer's disease, analyzing the use of biomarkers and neuropsychological testing for early detection. (Rev Med Chile 2012; 140: 1191-1200).
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Revista Médica de Chile, 2012,140, n° 9, p. 1191-1200
Keywords
Alzheimer disease, Biological markers, Neurobiology, Neuropsychology